ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
8,212.20
0.10%
S&P ASX All Technology
3,444.90
0.35%
Brent Oil
71.925
1.37%
US Dollar vs AUD
1.44735
-0.24%
Bitcoin
65,719.04
0.82%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. ENDRA Life Sciences Inc (NDRA)

  7. ENDRA Life Sciences Inc (NDRA) News

NDRA

ENDRA Life Sciences (NDRA)

ENDRA Life Sciences Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:NDRA
DateTimeSourceHeadlineSymbolCompany
17/09/202407:28Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:NDRAENDRA Life Sciences Inc
07/09/202406:33Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:NDRAENDRA Life Sciences Inc
29/08/202407:09Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NDRAENDRA Life Sciences Inc
29/08/202406:17Business WireENDRA Life Sciences Granted Extension to Regain Compliance with Nasdaq Continued Listing RequirementsNASDAQ:NDRAENDRA Life Sciences Inc
24/08/202406:06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NDRAENDRA Life Sciences Inc
23/08/202406:14Business WireENDRA Life Sciences Reports Second Quarter 2024 Financial Results and Provides a Business UpdateNASDAQ:NDRAENDRA Life Sciences Inc
17/08/202406:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NDRAENDRA Life Sciences Inc
16/08/202422:00Business WireENDRA Life Sciences Announces Reverse Stock SplitNASDAQ:NDRAENDRA Life Sciences Inc
16/08/202407:00Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:NDRAENDRA Life Sciences Inc
15/08/202406:06Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:NDRAENDRA Life Sciences Inc
14/08/202406:05Business WireENDRA Life Sciences Reschedules Second Quarter Conference Call to August 22, 2024NASDAQ:NDRAENDRA Life Sciences Inc
13/08/202423:24Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NDRAENDRA Life Sciences Inc
13/08/202423:24Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NDRAENDRA Life Sciences Inc
13/08/202422:00Business WireENDRA Life Sciences Announces Leadership ChangesNASDAQ:NDRAENDRA Life Sciences Inc
09/08/202422:02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NDRAENDRA Life Sciences Inc
07/08/202422:00Business WireENDRA Life Sciences to Report Second Quarter 2024 Financial Results on August 14NASDAQ:NDRAENDRA Life Sciences Inc
18/07/202406:16Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:NDRAENDRA Life Sciences Inc
18/07/202406:16Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NDRAENDRA Life Sciences Inc
15/06/202406:01Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:NDRAENDRA Life Sciences Inc
14/06/202422:00Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:NDRAENDRA Life Sciences Inc
13/06/202407:22Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:NDRAENDRA Life Sciences Inc
06/06/202422:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NDRAENDRA Life Sciences Inc
05/06/202422:20Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:NDRAENDRA Life Sciences Inc
05/06/202414:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:NDRAENDRA Life Sciences Inc
04/06/202423:21Business WireENDRA Life Sciences Announces Pricing of $8.0 Million Public OfferingNASDAQ:NDRAENDRA Life Sciences Inc
01/06/202406:21Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:NDRAENDRA Life Sciences Inc
20/05/202422:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NDRAENDRA Life Sciences Inc
20/05/202422:00Business WireENDRA Provides Update Following In-person Meeting with FDANASDAQ:NDRAENDRA Life Sciences Inc
15/05/202406:26Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:NDRAENDRA Life Sciences Inc
15/05/202406:17Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NDRAENDRA Life Sciences Inc
 Showing the most relevant articles for your search:NASDAQ:NDRA

Your Recent History

ASX
XTO
S&P ASX 100
NASDAQ
MSFT
Microsoft
PM
XAUUSD
Gold vs US Dollar
ASX
ORG
Origin Energy
NYSE
KO
Coca Cola
COIN
BTCUSD
Bitcoin
NYSE
DIS
Walt Disney
NASDAQ
TSLA
Tesla
COIN
SOLUSD
Solana
FX
AUDJPY
AUD vs Yen
ASX
XMM
S&P ASX 300 Metals and M...
ASX
XAO
Australian SE All Ordina...
NASDAQ
GOOGL
Alphabet
NYSE
NKE
Nike
ASX
NCM
Newcrest Mining
ASX
QBE
QBE Insurance
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved